DCH Arthritis Pain Relief Roll-On

openFDA label record#

This page contains supplementary openFDA label data. For the canonical label presentation, use the corresponding DailyMed Structured Product Label.

Verified complete openFDA source JSON (canonical bytes are SHA-256 checked before publication)

Brand name: DCH Arthritis Pain Relief Roll-On
Generic name: CAPSAISIN 0.1%
Manufacturer: Derma Care Research Labs, LLC
Product type: HUMAN OTC DRUG
SPL set ID: fda0d359-95eb-8b38-e053-6294a90a7b88
SPL ID: 29a4c442-7388-9481-e063-6294a90adaae
Version: 2
Effective date: 2024-12-19
Source export date: 2026-09-28
Source partition: 3
Source file: https://download.open.fda.gov/drug/label/drug-label-0003-of-0014.json.zip
Source object key: raw/openfda/drug-label/2026-09-28/fd09911bd1bc81f7f2faeb048e63855fe224e494376ae919a0035190e315c050/drug-label-0003-of-0014.json.zip
Source manifest SHA-256: cd2e66336a5cd2223fa3995098fdbdb84c6a7ee5c0a4addb236ccb22dd1e6887
Import run: 20260929T050834Z
Imported at: 2026-09-29 05:18:09

Harmonized routes table
Harmonized routes
TOPICAL

Harmonized identifier links#

Every typed identifier imported from the complete openFDA harmonization object is paginated here; values are not reduced to a first match.

Harmonized identifiers page 1 of 1 · 11 matching rows.

Type, Scope, Identifier table
Type	Scope	Identifier	Source field
application number		M017	openfda.application_number
brand name		DCH Arthritis Pain Relief Roll-On	openfda.brand_name
generic name		CAPSAISIN 0.1%	openfda.generic_name
manufacturer name		Derma Care Research Labs, LLC	openfda.manufacturer_name
ndc	package	72839-026-03	openfda.package_ndc
ndc	product	72839-026	openfda.product_ndc
ndc11	package	72839002603	derived:openfda.package_ndc
rxcui		2639091	openfda.rxcui
spl id		29a4c442-7388-9481-e063-6294a90adaae	id
spl set id		fda0d359-95eb-8b38-e053-6294a90a7b88	set_id
unii		S07O44R1ZM	openfda.unii

Warnings cross-check#

openFDA text is shown for search and cross-checking; DailyMed SPL is canonical.

Warnings sections page 1 of 1 · 1 matching rows.

warnings

For external use only. When using this product do not bandage tightly or cover treated area, do not use with heating pad, avoid contact with eyes and mucous membranes, do not apply to wounds, damaged, broken or irritated skin, a transient burning sensation may occur upon application but generally disappears in several days, if severe burning occurs, discontinue use immediately, do not expose the area treated with product to heat or direct sunlight. Stop use and ask a doctor if condition worsens, symptoms last more than 7 days or clear up and occur again within a few days, redness is present, or irritation develops.

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.